Trial NCT01131325

View at ClinicalTrials.gov 
Org. Study IDs: CAMN107AUS20

Last trial update was posted on 2021-05-20

MeSH Interventions

Nilotinib

MeSH Conditions

Leukemia Leukemia, Myelogenous, Chronic, BCR-ABL Positive Leukemia, Myeloid Philadelphia Chromosome

Other Conditions

CML Chronic Myelogenous Leukemia Chronic Phase(CML-CP) Patients With Low Imatinib Trough Levels Philadelphia Chromosome Positive (Ph+)

Stopping Reasons

N/A

Limitations And Caveats

The study was terminated early due to slow enrollment.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID